WuXi Bi­o­log­ics paus­es Mass­a­chu­setts build; No­vo Hold­ings nabs ma­jor­i­ty stake in phar­ma tools firm  

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more.

WuXi Bi­o­log­ics has “tem­porar­i­ly paused” the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.